Search results for: 'purotoxin 1'
- R1077 EZ Cap™ Mouse CD137 mRNA (m1Ψ, HA tag)Summary: Mouse CD137 mRNA with Cap 1 structure and HA tag sequence, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
- R1078 EZ Cap™ Mouse CD252(OX40L) mRNA (m1Ψ, HA tag)Summary: Mouse CD252 mRNA with Cap 1 structure and HA tag sequence, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
- R1079 EZ Cap™ Mouse CD80 mRNA (m1Ψ, HA tag)Summary: Mouse CD80 mRNA with Cap 1 structure and HA tag sequence, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
- R1102 EZ Cap™ EYFP mRNA (m1Ψ)Summary: Enhanced Yellow Fluorescent Protein (EYFP) mRNA with Cap 1 structure, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
- P1216 Recombinant Human I-309/CCL1Summary: Chemokine (C-C motif) ligand 1 (CCL1) belongs to a family inflammatory cytokines and also known as chemokines.
- BA1930 AurothioglucoseSummary: Aurothioglucose (Goldthioglucose) contains monovalent gold ions and is a potent active site inhibitor of (thioredoxin reductase 1).
- BA7810 MersalylSummary: Mersalyl (Salirgan) is a potent inducer of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor 1 (HIF-1).
- BA7847 VorasidenibSummary: Vorasidenib (AG-881) is an orally available, brain-permeable, second-generation dual inhibitor of mutant isocitrate dehydrogenase 1 and 2.
- BA8059 AZ3976Summary: AZ3976 is a potent fibrinogen activator inhibitor type 1 inhibitor at 26 μM in enzyme colorimetric analysis.
- BA5484 XanomelineSummary: Xanomeline increases neuronal excitability as a potent selective muscarinic type 1 and type 4 receptor agonist.